Published in Blood Weekly, November 17th, 2005
Study 1: Nucleophosmin (NPM) mutations were found in childhood acute myelogenous leukemia (AML) with normal karyotype.
"NPM is a nucleocytoplasmic shuttling protein involved in leukemia-associated chromosomal translocations, and it regulates the alternate reading frame (ARF)-p53 tumor-suppressor pathway. Recently, it has been demonstrated that mutations of the NPM1 gene alter the protein at its C-terminal, causing its cytoplasmic localization," researchers in Italy reported.
"Cytoplasmic NPM was detected in 35% of adult patients with primary...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2005-11-17)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.